K Sharma, S RamachandraRao, G Qiu, HK Usui … - The Journal of Clinical Investigation, 2008 - pubmedcentral.nih.gov 1 Translational Research in Kidney Disease, Division of Nephrology, Department
of Medicine, University of California, San Diego, La Jolla, California, USA. 2
Veterans Administration San Diego Healthcare System, La Jolla, California, ... Cited by 38 - Related articles - BL Direct - All 8 versions
SM Kutz, CE Higgins, R Samarakoon, SP … - Experimental cell research, 2006 - Elsevier Transforming growth factor-β1 (TGF-β1) transcriptionally regulates the
expression of genes that encode specific proteins (eg, plasminogen activator
inhibitor-1; PAI-1) important in stromal remodeling and cellular invasion. ... Cited by 28 - Related articles - All 5 versions
Y Zhu, HK Usui, K Sharma - Seminars in nephrology, 2007 - pubmedcentral.nih.gov The recognition of the drivers of matrix accumulation as a therapeutic target
for diabetic nephropathy is accepted by the Nephrology and pharmaceutical
community. Interventions focused around Transforming Growth Factor–beta ... Cited by 21 - Related articles - All 9 versions
- ►nih.gov S Huang, X Li, TM Yusufzai, Y Qiu, G … - Molecular and Cellular Biology, 2007 - Am Soc Microbiol The insulator element at the 5' end of the chicken ß-globin locus acts as a
barrier, protecting transgenes against silencing effects of adjacent
heterochromatin. We showed earlier that the transcription factor USF1 binds ... Cited by 17 - Related articles - BL Direct - All 6 versions
DW Cheng, Y Jiang, A Shalev, R Kowluru, ED … - Archives of Physiology and Biochemistry, 2006 - informahealthcare.com Renal mesangial cells play an important role in the development of diabetic
kidney disease. We have previously demonstrated that some of the effects of high
glucose on mesangial extracellular matrix (ECM) protein expression are ... Cited by 14 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org ME Dickson, MB Zimmerman, K Rahmouni, … - Hypertension, 2007 - Am Heart Assoc A number of naturally occurring polymorphisms exist in the human angiotensinogen
locus, some of which have been associated with essential hypertension,
preeclampsia, and other medical disorders. However, to date there has been ... Cited by 14 - Related articles - All 5 versions
UH Frey, H Hauner, KH Jöckel, I Manthey, N … - Pharmacogenetics and Genomics, 2008 - journals.lww.com Cited Here...: A G>A transition at position -1211 the human GNAS promoter (minor
allele frequency=0.36) was identified resulting in altered upstream stimulatory
factor 1 transcription factor binding, promoter activity, Gαs expression, ... Cited by 10 - Related articles - BL Direct - All 6 versions
- ►pnas.org B Nayak, P Xie, S Akagi, Q Yang, L Sun, J … - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences Biological properties of renal-specific oxidoreductase (RSOR), characteristics
of its promoter, and underlying mechanisms regulating its expression in diabetes
were analyzed. RSOR expression, normally confined to the renal cortex, was ... Cited by 10 - Related articles - BL Direct - All 10 versions
MR Saban, HL Hellmich, M Turner, NB Nguyen … - BMC physiology, 2006 - biomedcentral.com It was found that the control bladder mucosa presented regulatory elements
driving genes such as myosin light chain phosphatase and calponin 1 that
influence the smooth muscle phenotype. In the control detrusor network the ... Cited by 10 - Related articles - Cached - All 9 versions
R Saban, C Simpson, R Vadigepalli, S Memet … - BMC urology, 2007 - biomedcentral.com Tachykinins (TK), such as substance P, and their neurokinin receptors which are
ubiquitously expressed in the human urinary tract, represent an endogenous
system regulating bladder inflammatory, immune responses, and visceral ... Cited by 9 - Related articles - Cached - All 8 versions
